Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 18,60118,620 of 20,252 grants

Completed OTHER RESEARCH-RELATED
Increasing physical activity among breast cancer survivors: Use of the ORBIT Model to refine and test a novel approach to exercise promotion based on affect-regulation
NATIONAL CANCER INSTITUTE Dartmouth-Hitchcock Clinic United States 2021 – 2026

PROJECT SUMMARY/ABSTRACT The goal of this K08 Mentored Clinical Scientist Research Career Development Award is to prepare the candidate for an independent research career Breast ca...

$1.76M
USD
Completed TRAINING, INDIVIDUAL
The Identity of the Notch Ankyrin Repeat Domain as a Determinant of Isoform-Specific Notch Signaling
NATIONAL CANCER INSTITUTE Johns Hopkins University United States 2021 – 2024

Project Summary/Abstract: The Notch signaling pathway is a crucial regulator of development and cell differentiation in almost all animal organs and tissues. The Notch receptor is...

$737.7K
USD
Completed NON-SBIR/STTR RPGS
Targeting allosteric scaffolding functions of Aurora kinase A in cancer
NATIONAL CANCER INSTITUTE University of Minnesota United States 2021 – 2026

ABSTRACT Neuroblastoma is the most common solid tumor in infants. About 25% of patients have high-risk neuroblastoma, a devastating disease with poor prognosis and few treatment op...

$3.47M
USD
Completed NON-SBIR/STTR RPGS
New Hybrid Molecular Modalities Comprised of DNA-Origami and Interfering Peptides as Inhibitors of Protein-Protein Interactions
NATIONAL CANCER INSTITUTE George Mason University United States 2021 – 2024

PROJECT SUMMARY/ABSTRACT: New molecular modalities to target sites of protein-protein interaction with high affinity and specificity are desperately needed in cancer treatment. Blo...

$1.61M
USD
Completed OTHER RESEARCH-RELATED
Expanding the scope of protein degradation and stability using chemoproteomic platforms
NATIONAL CANCER INSTITUTE J. David Gladstone Institutes United States 2021 – 2025

Targeted protein degradation (TPD) has arisen as a powerful drug discovery platform for tackling the undruggable proteome by targeting specific proteins for proteasomal degradation...

$945.9K
USD
Completed TRAINING, INDIVIDUAL
Epigenetic regulators of subtype plasticity in bladder cancer
NATIONAL CANCER INSTITUTE Columbia University Health Sciences United States 2021 – 2024

Project Summary/Abstract Bladder cancer can be subdivided into two categories: non-muscle invasive bladder cancer (NMIBC) and muscle invasive bladder cancer (MIBC). NMIBC is treate...

$737.7K
USD
Completed TRAINING, INDIVIDUAL
TRANSCRIPTIONAL REPROGRAMMING OF ESR1 MUTANT BREAST CANCER IN METASTASIS AND TREATMENT RESISTANCE
NATIONAL CANCER INSTITUTE Baylor College of Medicine United States 2021 – 2024

Project Summary Up to 1 in 8 women in the United States will develop invasive breast cancer in their lifetime, with 70-80% of cases being estrogen receptor positive (ER+). These ca...

$476.9K
USD
Completed NON-SBIR/STTR RPGS
Pre-malignant mutation landscape and risk factors for progression to hematologic cancers
NATIONAL CANCER INSTITUTE Weill Medical Coll of Cornell Univ United States 2021 – 2026

ABSTRACT Clonal hematopoesis (CH) defined as the presence of acquired mutations detectable in peripheral blood of normal healthy individuals without hematologic malignancies (HM) h...

$6.51M
USD
Completed NON-SBIR/STTR RPGS
Addressing Chemoresistance in Pancreatic and Ovarian Cancers: Photodynamic Priming and Repurposing of Tetracyclines using Targeted Photo-Activable Multi-Inhibitor Liposome
NATIONAL CANCER INSTITUTE University of Maryland, College Park United States 2021 – 2026

ABSTRACT The prognosis for patients with advanced stage ovarian or pancreatic cancer has remained dismal for decades. The poor response rates result, in part, from resistance to sa...

$6.48M
USD
Completed NON-SBIR/STTR RPGS
Dissecting new mechanisms of lysosome quality control in health and disease
NATIONAL CANCER INSTITUTE University of California, San Francisco United States 2021 – 2026

PROJECT SUMMARY Lysosomes function as critical nodes for macromolecular recycling, metabolic rewiring, and pro-growth signaling in cells. Accordingly, defects in lysosome function...

$3.62M
USD
Completed NON-SBIR/STTR RPGS
Investigation of the role of epithelial-mesenchymal plasticity in renal cell carcinoma
NATIONAL CANCER INSTITUTE University of Tx Md Anderson Can Ctr United States 2021 – 2026

Sarcomatoid renal cell carcinoma (sRCC) represents an aggressive group of renal epithelial tumors characterized by histopathological features of epithelial–mesenchymal plasticity (...

$5.52M
USD
Completed NON-SBIR/STTR RPGS
Novel TYRO3 inhibitors for treatment of cancer
NATIONAL CANCER INSTITUTE University of North Carolina Chapel Hill United States 2021 – 2026

TYRO3 is a member of the TAM (TYRO3, AXL, MERTK) family of receptor tyrosine kinases. All three family members are aberrantly expressed in cancer cells, where they function to prom...

$3.17M
USD
Completed NON-SBIR/STTR RPGS
Targeting Lipid Metabolism in Colorectal Cancer
NATIONAL CANCER INSTITUTE University of Kentucky United States 2021 – 2026

PROJECT SUMMARYMetastasis is the main cause of death from solid tumors including colorectal cancer (CRC). Our long-term goal is to develop more selective therapeutic options to pre...

$3.4M
USD
Completed NON-SBIR/STTR RPGS
Harnessing Rare Variants for Tumor Classification
NATIONAL CANCER INSTITUTE Sloan-Kettering Inst Can Research United States 2021 – 2025

Abstract This project concerns how to extract clinically actionable information for diagnostic purposes from mutational patterns observed from tumor sequencing panels that are incr...

$3.97M
USD
Completed NON-SBIR/STTR RPGS
Structure-activity relationships governing mammalian SWI/SNF chromatin remodeling activity as a function of chromatin state
NATIONAL CANCER INSTITUTE Dana-Farber Cancer Inst United States 2021 – 2026

PROJECT SUMMARY Recent whole-exome sequencing studies in human cancer and neurodevelopmental disorders have unmasked frequent mutations in genes encoding chromatin regulatory prote...

$6.77M
USD
Completed TRAINING, INDIVIDUAL
Genetic Determinants of Evolutionary Trajectories and Clinical Course in Pancreatic Cancer
NATIONAL CANCER INSTITUTE Sloan-Kettering Inst Can Research United States 2021 – 2024

PROJECT SUMMARY Genetic intratumoral heterogeneity (gITH) has been associated with cancer progression and is thought to be a major contributor to treatment resistance. However, the...

$476.9K
USD
Completed TRAINING, INDIVIDUAL
Design and Application of Cationic Nanocarriers to Inhibit Breast Cancer Progression in Primary and Metastatic Sites
NATIONAL CANCER INSTITUTE Columbia University Health Sciences United States 2021 – 2023

PROJECT SUMMARY Triple-negative breast cancer (TNBC) is characterized by the lack of estrogen/progesterone receptors and human epidermal growth factor receptor 2 (HER2) expression...

$250.6K
USD
Completed NON-SBIR/STTR RPGS
Two photon fluorescence microscopy for dermatologic surgery and biopsy
NATIONAL CANCER INSTITUTE University of Rochester United States 2021 – 2026

Medicare reimburses over 5 million biopsies resulting in 1.5 million surgical procedures annually for nonmelanoma skin cancer (NMSC). Despite its burden on the health care system,...

$3.36M
USD
Completed NON-SBIR/STTR RPGS
Imaging and manipulating oncoprotein phase separation and compartmentalization
NATIONAL CANCER INSTITUTE University of California, San Francisco United States 2021 – 2026

Abstract MYC oncoproteins including c-Myc and MYCN are major drivers of human tumorigenesis. Expression of MYC is deregulated and enhanced in many types of human cancer. For instan...

$4.21M
USD
Completed NON-SBIR/STTR RPGS
A novel determinant of prostate cancer growth
NATIONAL CANCER INSTITUTE Cleveland Clinic Lerner Com-Cwru United States 2021 – 2026

Project Summary/Abstract Prostate cancer (CaP) will cause the deaths of more than 33,000 American men in 2020 because systemic treatments for metastatic CaP fail. Actionable target...

$3.16M
USD